- Home
- GV vs MYNZ Comparison
GV vs MYNZ Comparison
Compare GV & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- MYNZ
- Stock Information
- Founded
- GV 2013
- MYNZ 2021
- Country
- GV Canada
- MYNZ Germany
- Employees
- GV N/A
- MYNZ N/A
- Industry
- GV Other Consumer Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- MYNZ Health Care
- Exchange
- GV Nasdaq
- MYNZ Nasdaq
- Market Cap
- GV 6.8M
- MYNZ 7.9M
- IPO Year
- GV 2022
- MYNZ 2021
- Fundamental
- Price
- GV $1.56
- MYNZ $1.43
- Analyst Decision
- GV
- MYNZ Buy
- Analyst Count
- GV 0
- MYNZ 2
- Target Price
- GV N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- GV 732.1K
- MYNZ 530.2K
- Earning Date
- GV 11-14-2025
- MYNZ 12-29-2025
- Dividend Yield
- GV N/A
- MYNZ N/A
- EPS Growth
- GV N/A
- MYNZ N/A
- EPS
- GV N/A
- MYNZ N/A
- Revenue
- GV $7,773,905.00
- MYNZ $659,935.00
- Revenue This Year
- GV N/A
- MYNZ $26.06
- Revenue Next Year
- GV N/A
- MYNZ $4.97
- P/E Ratio
- GV N/A
- MYNZ N/A
- Revenue Growth
- GV N/A
- MYNZ N/A
- 52 Week Low
- GV $1.02
- MYNZ $1.28
- 52 Week High
- GV $9.60
- MYNZ $14.39
- Technical
- Relative Strength Index (RSI)
- GV 42.24
- MYNZ 40.70
- Support Level
- GV $1.52
- MYNZ $1.43
- Resistance Level
- GV $1.64
- MYNZ $1.63
- Average True Range (ATR)
- GV 0.11
- MYNZ 0.11
- MACD
- GV 0.00
- MYNZ -0.01
- Stochastic Oscillator
- GV 27.78
- MYNZ 19.35
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.